FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116743866> ?p ?o ?g. }

• W2116743866 endingPage "4668" @default.
• W2116743866 startingPage "4657" @default.
• W2116743866 abstract "We tested the combination of a tumor lysate vaccine with a panel of costimulatory molecules to identify an immunotherapeutic approach capable of curing established murine gliomas.Glioma-bearing mice were primed with a tumor lysate vaccine, followed by systemic administration of the following costimulatory ligands: OX40L, CD80, 4-1BBL, and GITRL, which were fused to the Fc portion of human immunoglobulin. Lymphocytes and mRNA were purified from the brain tumor site for immune monitoring studies. Numerous variations of the vaccine and Fc-OX40L regimen were tested alone or in combination with temozolomide.Lysate vaccinations combined with Fc-OX40L led to the best overall survival, yielding cure rates of 50% to 100% depending on the timing, regimen, and combination with temozolomide. Cured mice that were rechallenged with glioma cells rejected the challenge, showing immunologic memory. Lymphocytes isolated from the draining lymph nodes of vaccine/Fc-OX40L-treated mice had superior tumoricidal function relative to all other groups. Vaccine/Fc-OX40L-treated mice exhibited a significant increase in proliferation of brain-infiltrating CD4 and CD8 T cells, as indicated by Ki67 staining. Fc-OX40L had single-agent activity in transplanted and spontaneous glioma models, and the pattern of inflammatory gene expression in the tumor predicted the degree of therapeutic response.These data show that Fc-OX40L has unique and potent activity against experimental gliomas and warrants further testing." @default.
• W2116743866 created "2016-06-24" @default.
• W2116743866 creator A5003496300 @default.
• W2116743866 creator A5005197335 @default.
• W2116743866 creator A5021442843 @default.
• W2116743866 creator A5035935285 @default.
• W2116743866 creator A5036282836 @default.
• W2116743866 creator A5040421747 @default.
• W2116743866 creator A5072065475 @default.
• W2116743866 creator A5077143749 @default.
• W2116743866 creator A5077912416 @default.
• W2116743866 creator A5078553920 @default.
• W2116743866 creator A5081373240 @default.
• W2116743866 creator A5087054051 @default.
• W2116743866 creator A5091736003 @default.
• W2116743866 date "2012-08-30" @default.
• W2116743866 modified "2023-10-15" @default.
• W2116743866 title "An <i>In Vivo</i> Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas" @default.
• W2116743866 cites W1939942194 @default.
• W2116743866 cites W1965313675 @default.
• W2116743866 cites W1967997998 @default.
• W2116743866 cites W1968735524 @default.
• W2116743866 cites W1977179270 @default.
• W2116743866 cites W1985652465 @default.
• W2116743866 cites W1989384455 @default.
• W2116743866 cites W2001017617 @default.
• W2116743866 cites W2002250199 @default.
• W2116743866 cites W2014372297 @default.
• W2116743866 cites W2014492817 @default.
• W2116743866 cites W2024016266 @default.
• W2116743866 cites W2025322061 @default.
• W2116743866 cites W2044835625 @default.
• W2116743866 cites W2062956416 @default.
• W2116743866 cites W2065319085 @default.
• W2116743866 cites W2068640002 @default.
• W2116743866 cites W2086462344 @default.
• W2116743866 cites W2096287682 @default.
• W2116743866 cites W2097882623 @default.
• W2116743866 cites W2097995306 @default.
• W2116743866 cites W2098850271 @default.
• W2116743866 cites W2109904759 @default.
• W2116743866 cites W2113942802 @default.
• W2116743866 cites W2124333358 @default.
• W2116743866 cites W2133499518 @default.
• W2116743866 cites W2134907223 @default.
• W2116743866 cites W2137405984 @default.
• W2116743866 cites W2137930630 @default.
• W2116743866 cites W2161216730 @default.
• W2116743866 cites W2166659744 @default.
• W2116743866 doi "https://doi.org/10.1158/1078-0432.ccr-12-0990" @default.
• W2116743866 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3432688" @default.
• W2116743866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22781551" @default.
• W2116743866 hasPublicationYear "2012" @default.
• W2116743866 type Work @default.
• W2116743866 sameAs 2116743866 @default.
• W2116743866 citedByCount "34" @default.
• W2116743866 countsByYear W21167438662012 @default.
• W2116743866 countsByYear W21167438662013 @default.
• W2116743866 countsByYear W21167438662014 @default.
• W2116743866 countsByYear W21167438662015 @default.
• W2116743866 countsByYear W21167438662016 @default.
• W2116743866 countsByYear W21167438662017 @default.
• W2116743866 countsByYear W21167438662018 @default.
• W2116743866 countsByYear W21167438662019 @default.
• W2116743866 countsByYear W21167438662020 @default.
• W2116743866 countsByYear W21167438662021 @default.
• W2116743866 countsByYear W21167438662022 @default.
• W2116743866 countsByYear W21167438662023 @default.
• W2116743866 crossrefType "journal-article" @default.
• W2116743866 hasAuthorship W2116743866A5003496300 @default.
• W2116743866 hasAuthorship W2116743866A5005197335 @default.
• W2116743866 hasAuthorship W2116743866A5021442843 @default.
• W2116743866 hasAuthorship W2116743866A5035935285 @default.
• W2116743866 hasAuthorship W2116743866A5036282836 @default.
• W2116743866 hasAuthorship W2116743866A5040421747 @default.
• W2116743866 hasAuthorship W2116743866A5072065475 @default.
• W2116743866 hasAuthorship W2116743866A5077143749 @default.
• W2116743866 hasAuthorship W2116743866A5077912416 @default.
• W2116743866 hasAuthorship W2116743866A5078553920 @default.
• W2116743866 hasAuthorship W2116743866A5081373240 @default.
• W2116743866 hasAuthorship W2116743866A5087054051 @default.
• W2116743866 hasAuthorship W2116743866A5091736003 @default.
• W2116743866 hasBestOaLocation W21167438661 @default.
• W2116743866 hasConcept C150903083 @default.
• W2116743866 hasConcept C154317977 @default.
• W2116743866 hasConcept C167672396 @default.
• W2116743866 hasConcept C202751555 @default.
• W2116743866 hasConcept C203014093 @default.
• W2116743866 hasConcept C207001950 @default.
• W2116743866 hasConcept C2777389519 @default.
• W2116743866 hasConcept C2777701055 @default.
• W2116743866 hasConcept C2778227246 @default.
• W2116743866 hasConcept C2778297628 @default.
• W2116743866 hasConcept C39347974 @default.
• W2116743866 hasConcept C502942594 @default.
• W2116743866 hasConcept C55493867 @default.
• W2116743866 hasConcept C71924100 @default.
• W2116743866 hasConcept C86803240 @default.

• next